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Summary 
This study shows that in mice selectively depleted of neutrophils by treatment with a monoclonal 
antibody, RB6-8C5, listeriosis is severely exacerbated in the liver, but not in the spleen or peritoneal 
cavity during the crucial first day of infection. At sites of infection in the livers of neutrophil- 
depleted mice, Listeria monocytogenes grew to large numbers inside hepatocytes. By contrast, in 
the livers of normal mice neutrophils rapidly accumulated at infectious loci and this was associated 
with the lysis of infected hepatocytes that served to abort infection in these permissive cells. 
In the spleen the situation was different, in that depletion of neutrophils did not result in appreciable 
exacerbation of infection. In this organ intact infected cells, many of which appeared to be fibroblast- 
like stromal cells,  were found at loci of infection in the presence or absence of large numbers 
of neutrophils. This suggests that neutrophils are less effective at destroying L. monocytogenes-infected 
target cells in the spleen than in the liver. Consequently, at least during the first day, the organism 
remained free to multiply intracellularly in the spleen in cells that are permissive for its growth. 
Presumably, the same situation exists in the peritoneal cavity, because depleting neutrophils did 
not severely exacerbate infection initiated at this site. 
I 
t has been generally believed that Listeria monocytogenes is a 
facultative intracellular parasite that owes its virulence to 
its ability to survive and grow inside macrophages (1, 2). How- 
ever, it is now known that L. monocytogenes can invade and 
proliferate in cells other than macrophages (3-8), including 
liver parenchymal cells (3). Thus, although most of an intra- 
venous inoculum of L. monocytogenes is rapidly ingested and 
destroyed by liver Kupffer cells (9),  some organisms avoid 
this early defense mechanism and are able to parasitize un- 
derlying hepatocytes that appear to be devoid of any antilisterial 
defenses. Consequently, L. monocytogenes can grow inside these 
cells without killing them and go on to directly infect neigh- 
boring cells by inducing the formation of intercellular cyto- 
plasmic bridges (4, 10). In this way L. monocytogenes has the 
potential to infect large numbers of hepatocytes without having 
to confront phagocytic cells. However, under normal circum- 
stances this phase of the infectious process is brought under 
control when the permissive hepatocytes in which L. mono- 
cytogenes resides are lysed. This serves to release the organism 
into the extracellular space for ingestion and killing by profes- 
sional phagocytes. 
Evidence has been presented from this laboratory (9,  11, 
12) indicating that the task of lysing infected hepatocytes is 
achieved early in infection by neutrophils that rapidly accumu- 
late at infectious loci.  It is shown more recently (13)  that 
this same defense mechanism probably operates to destroy 
hepatocytes infected with other facultative intracellular bac- 
teria. However, the interpretation that neutrophils mediate 
lysis of infected hepatocytes is based on histological evidence 
showing that they are the predominant cells that accumulate 
at loci of infection in the liver during the first day, and that 
many of them make contact with,  or are in close physical 
proximity to, infected hepatocytes undergoing dissolution. 
When neutrophils were prevented from accumulating at in- 
fectious loci (9, 12) by treating mice with mAb directed against 
the CD11b chain of the CDllb/CD18  ~-2 integrin mole- 
cule, hepatocytes were not lysed and L.  monocytogenes con- 
tinued to replicate within them. Although convincing, these 
findings do not represent unequivocal evidence that neutro- 
phils are exclusively responsible for lysing infected hepato- 
cytes because it remains possible that small numbers of other 
CDllb-bearing cells other than neutrophils, which are not 
obvious in histological preparations, might have contributed 
to hepatocyte lysis. More direct evidence for an exclusive role 
of neutrophils in destroying infected hepatocytes would be 
provided by showing that in mice selectively depleted of neu- 
trophils, Listeria-infected  hepatocytes are not lysed, and in- 
fection is exacerbated. 
One purpose of the present study was to use this strategy 
to determine whether neutrophils are in fact required for lysing 
infected hepatocytes during early stages of infection. Its other 
purpose was to determine whether neutrophils play this early 
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use of anti-CD11b  mAbs was considered unsuitable for an- 
swering this second question because of reports showing that 
these mAb do not prevent extravasation of neutrophils into 
alI tissues  (14).  Therefore,  the early course of listeriosis  in 
the liver, spleen, and peritoneal cavity was examined in mice 
treated with a specific granulocyte-depleting mAb (15), RB6- 
8C5. The results show that, RB6-8C5, by selectively depleting 
neutrophils  to the extent that these cells were not  available 
for recruitment to infectious loci, caused severe exacerbation 
of infection in the liver, but not in the spleen or peritoneal 
cavity. 
Materials  and  Methods 
Mice.  Male CB6/F1 mice were obtained from the Trudean In- 
stitute Animal Breeding Facility. They were used when they were 
9-12 wk old. 
Bacteria.  A logarithmic-phase broth culture ofL. monocytogenes 
(strain EDG) was prepared as described previously (13) and stored 
frozen at  -70~  in  1-ml aliquots.  For each experiment vials of 
frozen bacteria were thawed, pelleted by centrifugation (16,000 g 
for 5 rain), resuspended, and diluted in sterile 0.9%  (wt/vol) sa- 
line to the required inoculum concentration. 
Experimental Infections.  Liver and spleen infections were estab- 
lished by intravenous inoculation of 104 CFU L. monocytogenes in 
a volume of 0.2 ml. At 12 and 24 h of infection, mice were killed 
by cervical dislocation, their livers and spleens removed and homo- 
genized separately, and 10-fold serial dilutions  of organ homogenates 
were plated on Trypticase-soy agar. Bacterial colonies were counted 
after incubation for 24 h at 37~  To establish infection in the peri- 
toneal cavity, mice were inoculated intraperitoneally with 5  x  106 
CFU of L. monocytogenes in a volume of 0.2 ml. At 12 and 24 h 
of infection mice were killed as above and peritoneal cells (PC) 1 
were collected.  PC were harvested by lavaging the peritoneal cavity 
twice with  3-ml volumes of ice-cold  PBS containing  20  U/ml 
heparin, using a syringe fitted with a 20-gauge needle. The perito- 
neal cavity was gently massaged before withdrawing the wash. Once 
collected, PC were kept on ice. Total cell counts were determined 
using a hemocytometer and trypan blue exclusion  staining.  For 
differential counts, aliquots of PC were pelleted by low-speed cen- 
trifugation (300 g for 5 min), resuspended in a few drops of FCS, 
and smeared onto glass slides with a fine camel hair paint brush. 
Smears were dried in a stream of warm air and stained with Diff 
Quik (Baxter Corp., Miami, FL). Differential counts were deter- 
mined by counting 200 consecutive cells in each smear. To deter- 
mine the number of bacteria recovered in the peritoneal wash,  1 
ml of PC was added to 4 ml sterile distilled water, vortex-mixed 
and sonicated to disrupt host cells,  and the sonicate then plated 
as above. To determine the number of host cell-associated  bacteria, 
PC were pelleted as above and the CFU of bacteria in the superna- 
tant determined. 
Treatment of Mice with mAb RB6-8C5.  RB6-8C5 is a rat IgG 
2b mAb that is said to cause specific depletion of mouse neutro- 
phils and eosinophils (15). The RB6-8C5 hybridoma was a kind 
gift from Dr. K. Coffman, DNAX Research Institute (Palo Alto, 
CA). mAb RB6-8C5 for depletion was obtained from mouse as- 
cites and partially purified by ammonium sulfate precipitation. An- 
tibody concentration was estimated from the height  of the IgG 
1 Abbreviation used in this paper: PC, peritoneal cells. 
peak eluting from an HPLC-size exclusion column, mAb RB6- 
8C5  was given intravenously in a dose of 0.25 mg 2 d  and 4 h 
before inoculation of bacteria. Control mice were left untreated. 
We felt that it was unnecessary to treat control mice with a con- 
trol mAb because in numerous published studies from this and other 
laboratories  the  administration  of similar  amounts  of isotype- 
matched antilymphocyte and anticytokine mAbs had no appreciable 
effect  on the course of listeriosis  during the first day. 
Cytofluorometry.  FITC was conjugated to RB6-8C5 (whole an- 
tibody) that had been purified to homogeneity by DEAE-sephacel 
ion exchange chromatography. A whole antibody FITC-conjugate 
of an isotype-matched mAb (labeled  at a threefold higher FITC 
to immunoglobulin ratio than for RB6-8C5) directed against KLH 
served as a control for nonspecific staining via Fc receptor binding. 
This mAb was produced in this institute by Dr. L. Johnson. The 
F(ab')2 fragment of rat IgG anti-Thy 1.2  (clone  30.H.12;  Amer- 
ican Type Culture Collection, Rockville, MD) was conjugated to 
biotin. FITC and biotin conjugation was carried out as previously 
described (16). These conjugates were used for one- or two-color 
cytofluorimetric analysis of single cell suspensions of spleen cells 
or lymph node cells as described elsewhere (16). For two-color anal- 
yses, cells were stained first with FITC-RB6 and then with bi- 
otinylated anti-Thy 1.2 and streptavidin-phycoerythrin (Molecular 
Probes Inc., Eugene, OR). Staining was carried out in buffer con- 
taining  100 #g/ml of normal rat IgG (Sigma Chemical Co., St. 
Louis, MO) to block nonspecific binding of RB6-8C5 to cells via 
their Fc receptors. This represents a 100-fold excess of normal IgG 
over the working concentration of FITC-RB6-8C5. To determine 
which cells are recognized by mAb RB6-8C5 in vivo, cardiac blood 
was collected from mice 1 h  after intravenous administration of 
this mAb. Erythrocytes were lysed by osmotic shocking in distilled 
water  and  RB6-8C5-positive  leukocytes  were  detected  using 
F(ab')2 FITC-conjugated polyclonal goat anti-rat antibody.  The 
conjugate alone failed to bind to leukocytes prepared as above from 
control mice (data not shown). Stained cells were analyzed using 
a FACScan |  cytofluorograph or they were sorted using a FACStar 
Plus |  cytofluorograph (both from Becton Dickinson & Co., Moun- 
tain View, CA) both fitted with Lysis II software. Cytocentrifuge 
smears of sorted cells were stained with Diff-Quik and examined 
by microscopy. 
Histology.  Mice were inoculated intravenously with 104 or 106 
CFU of L.  monocytogenes, and killed  at 24 h of infection.  Their 
livers and spleens were removed whole, cut into small pieces, and 
fixed in 10% buffered formalin for 24 h. Fixed tissue was dehydrated 
in ethanol and embedded in plastic 0B-4 embedding kit; Polysciences 
Inc., Warrington, PA). Thin sections (1-2 #M thick) were cut with 
glass knives, stained with MacNeal's tetrachrome stain, and exam- 
ined with  a Nikon-microphot Fx light  microscope. 
Results 
Specificity  and Depleting Capacity of mAb RB6-8C5.  It has 
been reported by others (15) that mAb RB6-8C5 specifically 
binds to and selectively depletes mature murine neutrophils 
and eosinophils. However, the published study does not present 
detailed cytofluorimetric data in support  of this interpreta- 
tion.  Moreover,  it was recently reported by another group 
(17)  that RB6-8C5  can bind  to a significant proportion  of 
CD8 §  and CD4 +  T  cells from naive mice and  from mice 
infected with L. monocytogenes.  Given this latter claim it was 
necessary to reexamine the specificity of RB6-8C5  for neu- 
trophils  and eosinophils before conducting  any in vivo ex- 
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by cytofluorimetric analysis  of its binding to isolated cells 
from the spleens of naive mice and from mice that had been 
infected 1 d earlier with 104 CFU of L. monocytogenes. This 
allowed the identification of RB6-SC5-positive resident spleen 
cells and cells recruited to infectious loci in the spleen during 
the first day of infection. Cells that stained with a fluores- 
cence intensity of >1.5 log were considered positive.  In a pre- 
liminary experiment a single cell suspension of spleen cells 
(10% of which were determined by differential counting to 
be neutrophils) was directly stained with FITC-RB6-SC5 
or with a control FITC-anti-KLH  mAb. Whereas 10.8% 
of this spleen cell population was RB6-8C5-positive,  only 
0.23% of the same population was positively stained by the 
control mAb. The failure of control mAb to stain was ex- 
pected, given the large excess of normal rat IgG used in the 
staining protocol. In view of this result, positive staining of 
cells with FITC-RB6-SC5  was considered to be specific in 
all  subsequent experiments. 
As shown in Fig.  I almost all (>90%) RB6-8C5-positive 
spleen cells fell within a single brightly staining population. 
The remaining few cells stained with much lesser intensity. 
When the total (bright plus dull) positive cell population 
(Fig. 1, population A) was positively sorted, smeared, stained, 
and examined by microscopy it was found to consist almost 
entirely of neutrophils with a few eosinophils and mononuclear 
cells. By contrast, when only the intensely stained popula- 
tion of cells (Fig.  1, population B) was sorted and examined, 
eosinophils were conspicuously absent, indicating that they 
were stained less intensely by RB6-8C5.  However, a small 
percentage of mononuclear cells remained which probably 
represented nonstaining cells that were bound to neutrophils 
via the Fc moiety of RB6-8C5 during sorting. This interpre- 
tation is based on the observation that when sorting of RB6- 
8C5 positive cells was carried out in the absence of nonspecific 
rat IgG, the number of mononuclear cells in the sorted popu- 
lation increased to ~50%,  and cell agglutination was ob- 
vious (not shown). To verify that mAb RB6-8C5 selectively 
binds to neutrophils in vivo, as well as in vitro, blood leuko- 
cytes taken from mice given the mAb I h earlier were exam- 
ined by cytofluorimetry as described in Materials and Methods. 
By 1 h, mAb RB6-8C5 had reduced the percentage of neu- 
trophils in blood to 3% of the total leukocytes. Despite this, 
when RB6-8C5-positive  leukocytes were positively sorted 
they were found by differential cell counting to be >95% 
neutrophils. 
To test whether RB6-8C5 binds to some T cells, as indi- 
cated by a recent publication (17), spleen cells and lymph node 
cells (pooled inguinal, mesenteric, and brachial lymph nodes) 
from mice infected 1, 2,  5,  and 8 d earlier with 104 or 103 
CFU ofL. monocytogenes  were dual stained with FITC-RB6- 
8C5 and streptavidin-phycoerythrin after being treated first 
with biotinylated anti-Thy 1.2. The cytofluorimetric profile 
of dual stained spleen cells from mice infected 1 d earlier is 
displayed in Fig. 2. It shows unequivocally that T cells failed 
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Figure 1.  Identification of RB6-8C5-positive spleen cells. Cells were 
stained with FITC-RB6-8C5 and positively sorted by flow cytometry on 
the basis of their high (>1.5 log) fluorescence intensity. Cytofluorometric 
data is presented  as a histogram  plot of a cell suspension from which 
autofluorescent cells have been gated out. Most RB6-8CS-positive  cells 
were contained in a single brightly staining cell population (B) with a 
few cells (A minus B) staining less intensely. After sorting, cytosmearing, 
and staining, differential  counts (inset) were performed on RB6-8C5-positive 
cell populations A and B, 90-95% of which were found to be neutrophils 
and eosinophils. 
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Figure 2.  Two-color cytofluorimetric analysis  of spleen  cells stained with 
RB6-8C5  and anti-Thy 1.2. Spleen cells from  a mouse inoculated 24 h 
earlier with L. monocytogenes were stained with FITC-RB6-8C5 (x-axis) 
and biotin-anti-Thy  1.2/streptavidin-phycoerythrin  (y-axis). Data are pre- 
sented as a contour plot of 80% logarithmic contours with a 1% threshold. 
No positive dual stained cells were detected, indicating that the antigen 
recognized by R.B6-8C5 is not present on T  cells. to stain with RB6-8C5. Identical results were obtained with 
spleen and lymph node cells harvested and  analyzed on all 
subsequent  days of infection  (data  not  shown). 
The efficiency of mAb RB6-8C5 for depleting neutrophils 
was  assessed  by  examining  its  effects on  blood  leukocyte 
numbers.  The results presented in Table 1 show that RB6- 
8C5 treatment resulted in 95% depletion of neutrophils from 
blood. Thus, by the time RB6-8CS-treated mice were inoc- 
ulated with Listeria  they had >15-fold fewer blood neutro- 
phils than control mice, but similar numbers of blood mono- 
cytes and lymphocytes. 
Effect of Treating Mice with mAb RB6-8C5 on the Early Course 
of Listeriosis in the Liver vs. the Spleen.  To determine the effects 
of depleting mice of neutrophils on the early course of listeri- 
osis, the growth of L. monocytogenes was determined in the 
livers and spleens of control mice and RB6-8C5-treated mice 
at 12 and 24 h of infection. Table 2 shows that by 12 h after 
intravenous  inoculation  of  104  CFU  of L.  monocytogenes 
there  were  10-fold  more  bacteria  in  the  livers  of RB6- 
8C5-treated mice than in the livers of control mice, and that 
by 24 h there were 140-fold more. In the spleen, in contrast, 
treating mice with mAb RB6-8C5 caused only a threefold 
exacerbation of infection during the same time period. These 
results indicate dearly, therefore, that in mice depleted of neu- 
trophils, the liver, but not the spleen, is far more permissive 
for the growth  of L.  monocytogenes. 
To determine why RB6-8C5 treatment severely exacerbates 
infection in the liver, but not in the spleen, these organs from 
control and mAb-treated mice were examined histologically 
24  h  after intravenous  inoculation  of 104  or  106  CFU  of 
L. monocytogenes. As shown in Fig. 3, and described in detail 
below,  loci of infection in the livers (Fig.  3 a)  and spleens 
Table  1.  Effect of Treating Mice with mAb RB6-8C5 
on Blood Leukocyte Numbers 
Leukocytes 
Mice  Lymphocytes  Monocytes  Neutrophils 
Controls 
(n  =  5) 
RB6-treated 
(n  =  4) 
per mm 3 blood +_ SD 
6620  _+  1520  328  _+  152  1100  _+  550 
4920  _+  492  402  _+  156  61  -+  42 
RB6-8C5-treated mice received  0.25 mg of mAb intravenously 2 d and 
4 h earlier. Smears were made of peripheral blood collected  from tail veins. 
(Fig. 3 b) of control mice were populated by large numbers 
of neutrophils. By contrast, in RB6-8C5-treated mice, neu- 
trophils  were conspicuously absent  from infectious foci in 
the liver and spleen, and from the blood circulating in these 
organs.  Instead, loci of infection in the liver (Fig. 4 a) con- 
sisted of small groups of infected, morphologically intact he- 
patocytes some of which were very heavily infected, whereas 
others were less  so.  Presumably,  L.  monocytogenes grew to 
large numbers inside initially infected hepatocytes and then 
went on to directly infect neighboring hepatocytes at points 
of plasma membrane contact. This has been shown to be the 
case for intestinal epithelial cells in vivo (4) and a variety of 
other mammalian cells in vitro (10,  18,  19).  In the spleen, 
by contrast, infectious loci in RB6-treated mice consisted of 
lightly infected cells in the marginal zone of the white pulp 
Table  2.  Recovery  of Viable Bacteria from  the Livers and Spleens of Control and RB6-8C5-treated  Mice after Intravenous 
Inoculation of L.  monocytogenes 
L.  monocytogenes 
12 h  24 h 
Mice  Liver  Spleen  Liver  Spleen 
Control  4.38  _+  0.16 
RB6-8C5- 
treated  5.42  +  0.18 
Log~o CFU  +_  SD 
4.75  _+ 0.07  5.07  _+ 0.15  5.78  _+ 0.11 
4.70  _+ 0.15  7.22  _+ 0.08  6.16  _+ 0.11 
RB6-8C5-treated mice received  0.25 mg of mAb intravenously 2 d and 4 h before intravenous inoculation of 104 CFU of L. monocytogenes. Control 
mice were untreated. Five mice per group were used. 
Figure 3.  Foci  of L. monocytogenes infection in (a) the livers and (b) the spleens of infected control mice. By 24 h, loci of infection in the liver 
were indicated by large accumulations of neutrophils that occupied space originally occupied by parenchyma. At the peripheries of the microabscesses 
neutrophils are seen in close  contact with infected hepatocytes  (arrows)  that are undergoing lysis. In the spleen, as in the liver, neutrophils were numerous 
at loci of infection. However, in contrast to the situation in the liver, intact infected cells (arrows and insets)  are present in the centers of lesions in 
the spleen. This suggests that infected target cells in the spleen are less prone to destruction by neutrophils than are infected hepatocytes. Numbered 
insets show enlargements of cells indicated by arrows. Bar, 10/.tm. 
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the infected spleen cells was not determined by the present 
study, but many of them had the morphology and staining 
characteristics of recently described cells referred to as barrier 
cells (20), which are reticulum-like cells of uncertain func- 
tion and origin,  and usually present in the spleen in small 
numbers. Regardless of their identity, the histologic findings 
reported here suggest that target spleen cells in which L. mono- 
cytogenes resides are much less permissive for its growth than 
are hepatocytes. Thus, in the absence of neutrophils far more 
bacteria were found in individual hepatocytes than in individual 
spleen cells by 24 h  of infection. 
It is  obvious from Fig.  3  a  that  in  the livers of control 
mice, neutrophils that populate infectious loci occupy space 
once occupied by hepatocytes. This means that the hepato- 
cytes that occupied the space must have been lysed. According 
to Fig. 4 a  they would have been infected to one degree or 
another with L. monocytogenes  before lysis occurred. Indeed, 
at the peripheries of liver lesions in control mice, neutrophils 
were found in close physical contact with infected hepato- 
cytes that were in the process of being destroyed. In the spleens 
of control mice, as in the livers, infectious loci were also in- 
dicated by accumulations of neutrophils in the marginal zone 
and red pulp.  Bacteria were found in these microabscesses 
inside intact fibroblast-like resident spleen cells (Fig. 4 b) and 
occasionally inside neutrophils.  Although bacteria seen in- 
side neutrophils might have come from initially infected spleen 
cells that had lysed, selective destruction of infected spleen 
cells in  the vicinity of neutrophils  was  not  obvious. 
Effect of Treating Mice with mAb RB6-8C5 on Bacterial Growth 
in,  and  Neutrophil  Recruitment  to,  the  Peritoneal  Cavity. 
Based on visual assessment of liver and spleen sections it seemed 
obvious that RB6-8C5  treatment depleted mice of neutro- 
phils to the extent that few, if any, were available for recruit- 
ment to loci of infection. To demonstrate quantitatively the 
paucity of neutrophils available for recruitment to infectious 
loci an experiment was performed that measured the effects 
of RB6-8C5  pretreatment  on the accumulation  of neutro- 
phils  in  the  peritoneal  cavities  of  mice  inoculated  in- 
traperitoneally with L. monocytogenes.  This experiment also 
examined the need for neutrophils to restrict early bacterial 
proliferation in the peritoneal cavity, as an example of infec- 
tion in an extravascular compartment. To this end, the influx 
of inflammatory cells into the peritoneal cavities of control 
and RB6-SC5-treated mice was measured 12 and 24 h after 
intraperitoneal inoculation of 5  x  106 CFU of L. monocyto- 
genes. Table 3 shows that in uninfected mice resident perito- 
neal leukocytes consisted mainly of macrophages and lym- 
Table  3.  Effect of Treating Mice with mAb RB6-8C5  on Peritoneal Exudate  Cell Composition and Bacterial Numbers 
after Intralveritoneal Inoculation of L.  monocytogenes 
Peritoneal exudate cells 
Time after  Total  Log10 
Mice  inoculation  leukocytes  Lymphocytes  Macrophages  Neutrophils  bacteria 
x  104 
Uninfected 
controls  -  337  +  79  221  +  55  107  +_ 37  2  _+ 0.24  - 
Infected 
controls  12 h  586  _+  290  286  +  117  96  _+  61  206  +  108  4.21  +  0.25 
mAb-treated 
infected  12 h  389  +  48  254  _+ 43  113  _+  26  14  +  67  4.58  +  0.13 
Infected 
controls  24 h  1,070  +  230  304  _+  78  410  _+  89  344  _+  111  4.30  _+ 0.14 
mAb-treated 
infected  24 h  456  _+ 240  264  _+  148  169  _+  75  12  _+  14.6  5.04  _+ 0.37 
RB6-8C5-treated mice received 0.25 mg of mAb intravenously 2 d and 4 h before intraperitoneal inoculation of 5  x  106 CFU L. monocytogenes. 
Control mice were untreated. Values shown are the mean _  SD using four mice per group. 
Figure 4.  Foci  of L. monocytogenes  infection in (a) the livers and (b) the spleens of mice depleted of neutrophils by treatment with mAb RB6-8C5. 
In the livers of neutrophil-depleted mice loci of infection consisted of groups of infected hepatocytes that appeared morphologically intact. Initially 
parasitized hepatocytes within infectious loci harbor large numbers of bacteria, whereas adjacent hepatocytes are less heavily infected. In the spleen, 
by contrast, L. monocytogenes  did not grow to large numbers within individual infected cells. Many of the infected cells in the spleen had the morpho- 
logical appearance of fibroblast-like barrier cells (arrows  and insets). Numbered insets represent enlargements of cells indicated by arrows. Bar, 10 #m. 
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mice during the first 12 h after inoculation, there was a large 
influx of neutrophils into the peritoneal cavity, but no in- 
crease in the numbers of macrophages or lymphocytes. In 
the peritoneal cavities of RB6-8C5-treated mice, by contrast, 
by 12 h of infection there were 15-fold fewer recoverable neu- 
trophils, representing an '~95%  decrease in the number of 
these cells.  However, at 12 h  there was no decrease,  in the 
number of macrophages or lymphocytes. Despite this selec- 
tive decrease in the influx of neutrophils, there was little in- 
crease over control infected mice in the number of bacteria 
recovered from the peritoneal cavities of RB6-8C5-treated 
infected mice. This suggests that neutrophils were not neces- 
sary to restrict the growth of L. monocytogenes in the perito- 
neal cavity during the first 12 h. 
At 24 h  of infection large numbers of neutrophils were 
present in the peritoneal cavities of control infected mice, and 
there was a threefold increase in the numbers of macrophages. 
The number of lymphocytes, however, remained constant. 
By contrast, in RB6-8CS-treated mice at 24 h of infection, 
as at  12 h  of infection, neutrophil numbers were low and 
there were approximately twofold fewer macrophages than 
in the peritoneal cavities  of infected control mice. Because 
the antigen on neutrophils recognized by mAb RB6-8C5 
reportedly is not expressed on macrophages, the observed de- 
crease in the numbers of these cells in the peritoneal cavity 
in  mAb-treated  mice  might  indicate  the  abolition  of a 
neutrophil-dependent macrophage recruitment mechanism. 
As for the effect of RB6-8C5  treatment on infection in 
the peritoneal cavity, some fivefold more Listeria were recov- 
ered from the peritoneal cavities of treated mice than from 
control mice at 24 h of infection. Although substantial, this 
increase is  small  compared with  the increase in  bacterial 
numbers that occurs in the livers of RB6-8C5-treated mice. 
Indeed, there was little, if any, net bacterial growth between 
12 and 24 h in the peritoneal cavities  of infected control or 
infected mAb-treated mice. Moreover, in both cases >80% 
of the recoverable bacteria was pelleted by low speed (300 
g) centrifugation suggesting that they were cell associated. 
In  smears of peritoneal cells  from RB6-8C5-treated  mice 
<1% of macrophages were seen to contain L. monocytogenes 
bacteria, and then only in small numbers (<10 per macro- 
phage). It is possible that these infected macrophages might 
be the natural reservoirs of L. monocytogenes infection in the 
peritoneal cavity, possibly because they are defective in their 
ability to kill this organism. 
Discussion 
According  to  the  present  study,  treating  mice with  a 
granulocyte-specific mAb, RB6-8C5, abolishes a host defense 
mechanism  that  is  critical  for  restricting  the  growth  of 
L. monocytogenes in the liver during the first day of infection. 
According to the original description ofmAb RB6-8C5 (15), 
it recognizes an antigen only present on mature eosinophils 
and neutrophils, and specifically depletes these granulocytes 
in vivo. The cytofluorimetric, hematological, and histolog- 
ical findings presented here support this claim by showing 
that FITC-RB6-8C5-stained neutrophils and eosinophils al- 
most exclusively in a highly heterogeneous single cell sus- 
pension of spleen cells, and that RB6-8C5 treatment of mice 
selectively depleted them of blood neutrophils to numbers 
that were insufficient to subsequently populate loci of infec- 
tion in the liver and spleen. That the surviving neutrophils 
in RB6-8C5-treated  mice did not appear to focus to sites 
of liver or spleen infection might indicate a defect in their 
ability to do so, perhaps because of their having bound small 
amounts of mAb, or because they were RB6-8C5-negative 
immature cells, mAb RB6-8C5 was shown not to bind to 
T cells by the present study, a result not in agreement with 
the findings of others (17). The reason for this discrepancy 
is not obvious at this time, but might reflect differences in 
the reagents and staining methodologies used. 
Although RB6-8C5 clearly binds to eosinophils, it is ap- 
parent that these cells are not found at foci ofL. monocytogenes 
infection.  It is reasonable to conclude, therefore, that  the 
infection-enhancing action of RB6-8C5 in the liver is due 
to its ability to selectively deplete neutrophils thereby making 
them unavailable for recruitment to  infectious loci.  This 
strategy of specifically depleting mice of neutrophils shows 
in a more direct way than was previously shown with anti- 
CD11b-treated mice, the critical role that neutrophils play 
in defense against listeriosis of the liver. Although anti-CDllb 
mAbs prevented neutrophils from accumulating at infectious 
loci in the liver and caused exacerbation of infection in this 
organ, CD11b is not neutrophil-specific, but is also present 
on macrophages (3), certain T cells (21), and NK cells (22). 
However, given the evidence for the specificity of RB6-8C5 
presented here, the results obtained with this mAb would 
appear to leave little doubt that neutrophils that accumulate 
at loci of infection in the liver, rather than other leukocytes, 
are responsible for early defense involving the lysis of infected 
hepatocytes. Moreover, it is clear from this and preceding 
studies (9, 11, 12) that neutrophils serve their protective func- 
tion by destroying infected hepatocytes before L. monocytogenes 
has had the time to grow to large numbers within them. 
According to other results presented here, most of the fore- 
going discussion does not apply to the function of neutro- 
phils at other sites of L.  monocytogenes infection. Thus, in 
contrast to the situation in the liver, treating mice with RB6- 
8C5 caused very little exacerbation of infection in the spleen, 
indicating that neutrophils are not as important in anti-listerial 
defense in this organ as in the liver during the first day of 
infection. This was surprising given the predominance of neu- 
trophils at loci of infection in the spleen by 24 h after inocu- 
lation. Histological evidence indicates that neutrophils failed 
to substantially restrict L. monocytogenes multiplication in the 
spleen because the cells in which Listeria resides in this organ 
are less permissive for its growth than are hepatocytes. Even 
in the absence of neutrophils L. monocytogenes was not found 
in large numbers inside individual infected spleen cells. The 
evidence presented here is also consistent with the interpre- 
tation that infected target cells in the spleen are not lysed 
by neutrophils. The situation in the peritoneal cavity appears 
similar to that in the spleen, in that depleting mice of neu- 
trophils did not result in severe exacerbation of infection ini- 
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are normally lysed by neutrophils was not revealed by the 
present study. By contrast to these results,  recent studies in 
our laboratory (unpublished data) showed that anti-CDllb 
mAbs failed to prevent recruitment of neutrophils to loci of 
Listeria infection in the spleen and peritoneal cavity, yet caused 
substantial exacerbation of infection in these two compart- 
ments during the first day. This failure of anti-CD11b mAbs 
to inhibit neutrophil recruitment into some tissues agrees with 
the findings of  others (14, 23), and suggests that the infection- 
enhancing action of these mAbs in the spleen and peritoneal 
cavity is based on their ability to interfere with the antibac- 
terial functions of phagocytes (24). 
At the sites examined in the present study, neutrophil- 
mediated lysis of infected target cells as a strategy for con- 
trolling L. monocytogenes proliferation seemed to operate effec- 
tively only in the liver. However, this defense mechanism might 
be important at other sites not examined here.  In this re- 
spect, the reported destruction ofListeria-infected  enterocytes 
in areas of neutrophil accumulation in vivo after oral inocu- 
lation of bacteria into guinea pigs (4) is interesting given that 
enterocytes are very permissive  for L. monocytogenes  in vitro 
(6,  18). 
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